OTC:VPRO

Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal

WASHINGTON and CRANBURY, New Jersey, Feb. 26, 2013 /PRNewswire/ -- Viropro, Inc. (OTC: VPRO) and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement. Under the agreement, Viropro will have the rights to manufacture six monoclonal antibody products being developed...

2013-02-26 00:50 2184

Week's Top Stories